SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-105621
Filing Date
2009-05-08
Accepted
2009-05-08 17:26:28
Documents
8
Period of Report
2009-05-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 30624
2 FORM OF RESTRICTED STOCK UNIT AGREEMENT dex102.htm EX-10.2 109959
3 FORM OF STOCK OPTION AGREEMENT dex103.htm EX-10.3 117284
4 AMGEN INC. 2009 PERFORMANCE AWARD PROGRAM dex104.htm EX-10.4 47608
5 FORM OF PERFORMANCE UNIT AGREEMENT dex105.htm EX-10.5 99167
6 AMGEN INC. 2009 DIRECTOR EQUITY INCENTIVE PROGRAM dex106.htm EX-10.6 32187
7 FORM OF GRANT OF NON-QUALIFIED STOCK OPTION AGREEMENT dex107.htm EX-10.7 37884
8 FORM OF RESTRICTED STOCK UNIT AGREEMENT dex108.htm EX-10.8 32507
  Complete submission text file 0001193125-09-105621.txt   508963
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 09811985
SIC: 2836 Biological Products, (No Diagnostic Substances)